Riskpilot← Back to searchSign inGet full accessNEUROFYSIOTERAPIEN ApS
APSActiveCVR 30068181Sønderlandsgade 24Physiotherapy activities · NACE 8695Est. 20061 employees
Revenue 2024
DKK 730K
+26% vs 2023
EBITDA margin
2.3%
-4% vs 2023
Equity ratio
63.2%
Financial strength
Net profit 2024
DKK 13K
-7% vs 2023
| Revenue | DKK 730K | +26% |
| EBITDA | DKK 17K | -4% |
| Net profit | DKK 13K | -7% |
| Total assets | DKK 406K | +2% |
| Equity | DKK 257K | +5% |
| Employees | 1 | — |
Legal name
NEUROFYSIOTERAPIEN ApS
CVR number
30068181
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
23. november 2006
Share capital
DKK 62.500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er fysioterapi og genoptræning og dermed beslægtet virksomhed og salg.
Address
Sønderlandsgade 24
Phone
+4596102045
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 666 | 1.035 | 890 | 968 | 814 | 558 | 333 | 613 | 581 | 542 | 485 | 579 | 730 |
| Staff expenses | -642 | -907 | -861 | -962 | -806 | -548 | -356 | -585 | -569 | -517 | -520 | -561 | -713 |
| EBITDA | 24 | 129 | 29 | 6 | 8 | 10 | -23 | 28 | 12 | 25 | -36 | 18 | 17 |
| Depreciation & amort. | -6 | -6 | -7 | -3 | -3 | -5 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 18 | 122 | 22 | 3 | 5 | 5 | -23 | 28 | 12 | 25 | -36 | 18 | 17 |
| Net financials | -1 | -0 | -0 | -1 | -0 | -0 | -0 | -1 | -3 | -4 | -3 | 1 | 1 |
| Profit before tax | 17 | 122 | 21 | 3 | 5 | 5 | -23 | 27 | 9 | 20 | -38 | 18 | 18 |
| Tax | 5 | 32 | 5 | 2 | 1 | 1 | -3 | 7 | 2 | 5 | -8 | 4 | 5 |
| Net profit | 12 | 90 | 16 | 0 | 4 | 4 | -20 | 20 | 7 | 15 | -30 | 14 | 13 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 301 | 635 | 562 | 975 | 909 | 694 | 307 | 551 | 618 | 599 | 398 | 397 | 406 |
| Equity | 187 | 277 | 293 | 293 | 297 | 301 | 219 | 239 | 246 | 261 | 230 | 244 | 257 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 113 | 357 | 268 | 678 | 611 | 393 | 88 | 311 | 373 | 338 | 168 | 153 | 148 |
| Total debt | 113 | 357 | 268 | 678 | 611 | 393 | 88 | 311 | 373 | 338 | 168 | 153 | 148 |
EBITDA margin
2.3%
This company
15.8%
Market median
-85% vs market
20122024
Equity ratio
63.2%
This company
38.2%
Market median
+65% vs market
20122024
Return on equity
5.0%
This company
18.4%
Market median
-73% vs market
20122024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20122024
Asset turnover
1.80×
This company
1.12×
Market median
+61% vs market
20122024
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BO Founder | Founder | 2006 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NEUROFYSIOTERAPIEN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birte Obel Jepsen | Founder | 0 companies |